September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 09, 2025

Merger Cure? Rural Hospitals Try Networks

Mobile magnetic resonance imaging units and rural hospital networks support independent hospitals in improving access to diagnostic imaging and patient care in underserved areas.

KFF Health News

September 09, 2025

ACOG Reaffirms COVID-19 Vaccine Guidance

 Although CDC recently removed its explicit pregnancy and lactation call-out for the updated COVID-19 vaccine, ACOG is standing firm.

Conexiant

September 08, 2025

FDA Expands Indications for Von Willebrand Disease

FDA expands Vonvendi to adult routine prophylaxis (types 1 and 2) and pediatric on-demand/perioperative use.

Conexiant

September 05, 2025

Review Finds Misdiagnosis and Referral Delays in Endometriosis

Symptom dismissal, misdiagnosis, and long waits for referral contribute to delays in diagnosis and treatment.

Conexiant

September 03, 2025

Mifepristone as a Potential Option for Breast Cancer Prevention?

A global workshop focuses on repurposing a long-available therapy for oncology care.

Conexiant

September 03, 2025

FDA Approves Denosumab Biosimilars

The FDA approved Bildyos and Bilprevda are providing new options comparable to Prolia and Xgeva for osteoporosis, cancer-related bone disease, and other skeletal conditions.

Conexiant

September 03, 2025

CDC Leadership Changes May Impact Vaccine Guidance

Leadership changes at the CDC could affect vaccine guidance and public health policy, with potential implications for physicians and patient care.

KFF Health News

September 02, 2025

OTC Contraception Pill Linked to More Birth Control Starts

Over-the-counter access to progestin-only oral contraceptives shows higher use among patients with prior pregnancies and those not receiving recent contraceptive counseling.

Conexiant